Clinical Characteristics and Outcomes in Patients With Cryptococcaemia From a Large Population‐Based Cohort
Cryptococcus BSI is a highly lethal condition, particularly among non-HIV infected individuals. We highlight the prognostic importance of blood culture collection in patients with suspected cryptococcal infection. Identifying contemporary risk factors for mortality is critical to understanding what drives poor outcomes. There is a need for continued surveillance of fluconazole susceptibility among Cryptococcus species.
Authors
- Kevin B. Laupland (ORCID: https://orcid.org/0000-0002-1205-5354)
- Adam G. Stewart (ORCID: https://orcid.org/0000-0002-7262-7529)
- Monica A. Slavin (ORCID: https://orcid.org/0000-0002-8443-314X)
- Sarah P. Hammond (ORCID: https://orcid.org/0000-0002-4271-7443)
- Sophia Koo (ORCID: https://orcid.org/0000-0002-4973-7439)
- Ian Gassiep (ORCID: https://orcid.org/0000-0003-3548-6963)
- Sharon C.‐A. Chen (ORCID: https://orcid.org/0000-0002-9983-6603)
- Felicity Edwards (ORCID: https://orcid.org/0000-0002-9896-841X)
Institutions
- Brigham and Women's Hospital (US)
- The University of Sydney (AU)
- Harvard University (US)
- Queensland University of Technology (AU)
- The University of Queensland (AU)
- The University of Melbourne (AU)
- Royal Brisbane and Women's Hospital (AU)
- Peter MacCallum Cancer Centre (AU)
- Taronga Conservation Society Australia (AU)
- Westmead Hospital (AU)
- Massachusetts General Hospital (US)
- Dana-Farber Cancer Institute (US)
- Mater Private Hospital (AU)
- Center for Cancer Research (US)
- Mater Adult Hospital (AU)
Publication Details
- Journal
- Mycoses
- Published
- 2025-07-01
- DOI
- https://doi.org/10.1111/myc.70091
- Citations
- 1
- Primary Topic
- Fungal Infections and Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.35